Pacira BioSciences, Inc. PCRX Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s common stock, shares authorized (in shares)?
- Pacira BioSciences, Inc. (PCRX) reported common stock, shares authorized (in shares) of $250M in Q1 2026.
- How has Pacira BioSciences, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Pacira BioSciences, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $250M to $250M.
- What is the long-term trend for Pacira BioSciences, Inc.'s common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $250M to $250M.